Company news

Aethlon Medical, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update

August 13, 2024

Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial

August 11, 2024

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024

August 5, 2024

Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update

June 26, 2024

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024

June 20, 2024

Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial

June 17, 2024

Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies

June 2, 2024

Aethlon Medical Announces Pricing of $4.7 Million Public Offering

May 14, 2024

Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma

May 9, 2024

Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices

February 20, 2024

Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update

February 13, 2024

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024

February 6, 2024

Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update

November 13, 2023

Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer

November 12, 2023

Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023

November 5, 2023

Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncology

October 9, 2023

Aethlon Announces Reverse Stock Split

October 3, 2023

Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference

August 29, 2023

Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Update

August 9, 2023

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023

August 2, 2023

Aethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for Transplant

July 23, 2023

Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors

July 5, 2023

Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update

June 27, 2023

Aethlon Medical to Release Fourth Quarter and Year End Financial Results and Host Conference Call on June 28, 2023

June 21, 2023

Aethlon Medical Announces Investigation of the Hemopurifier® for Use in Organ Transplantation

June 20, 2023

Aethlon Medical to Participate in the Healthcare Virtual Conference Presented by Maxim Group and Hosted by M-Vest

June 13, 2023

Aethlon Medical to Present at the 13th Annual LD Micro Invitational

May 31, 2023

Aethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier® to Treat Severe COVID-19 in India

May 21, 2023

Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update

February 12, 2023

Correction: Aethlon Medical, Inc.

February 5, 2023

Aethlon Medical to Present at Sequire Biotechnology Conference on February 2nd, 2023

January 30, 2023

Aethlon Medical Announces Contract with NAMSA to Advance Hemopurifier Clinical Programs in Cancer

January 29, 2023

Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update

November 13, 2022

Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2022

November 1, 2022

Aethlon Medical to Present at Two Investor Conferences in September

September 5, 2022

Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update

August 8, 2022

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2022

August 2, 2022

Aethlon Medical Announces Publication of Peer-Reviewed Journal Article Describing Hemopurifier Resin Binding of Seven COVID-19 Variants

July 27, 2022

Aethlon Medical Announces U.S. FDA Approval of Hemopurifier COVID-19 Study Protocol Amendment

July 10, 2022

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 28, 2022

June 20, 2022

Aethlon Medical, Inc. Appoints Angela Rossetti to Board of Directors

March 27, 2022

Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 14, 2022

January 30, 2022

Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 9, 2021

November 1, 2021

Aethlon Medical Announces Peer-Reviewed Publication of Two Case Studies of Critically Ill COVID-19 Patients Treated with the Hemopurifier®

October 11, 2021

Aethlon Medical Announces Contracting with PPD to Advance Hemopurifier Clinical Programs

September 29, 2021

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2021

July 28, 2021

Aethlon Medical to Release Fourth Quarter Financial Results and Host Conference Call on June 24, 2021

June 20, 2021

Aethlon Medical Announces $12.425 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

June 9, 2021

Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 10, 2021

February 3, 2021

Aethlon Medical Expands Leadership Team with Appointment of Chief Business Officer and Chief Medical Officer

January 5, 2021

← Newer news releases · Older news releases →

Calls

The 5 newest of 17 calls. Every call is listed under its year.

Decks

The 5 newest of 33 decks. Every deck is listed under its year.